The Centers for Medicare & Medicaid Services today finalized a new Center for Medicare and Medicaid Innovation payment model aimed at transforming kidney care to ensure patients with chronic kidney disease have access to high quality, coordinated care.

The End-Stage Renal Disease Treatment Choices model will be mandatory for dialysis facilities and managing clinicians in certain areas of the country beginning Jan. 1, and test whether greater use of home dialysis and kidney transplantation for Medicare beneficiaries with ESRD reduce expenditures while preserving or enhancing quality of care.

The model’s payment adjustments will begin in January and run through June 30, 2027.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services released an updated notice Nov. 20 on the processing of Medicare provider claims impacted by the government…
Headline
The Medicare Part A deductible for inpatient hospital services will increase by $60 in calendar year 2026 to $1,736, the Centers for Medicare & Medicaid…
Headline
Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing…
Headline
The 43-day government shutdown ended last night when President Trump signed a funding bill into law, hours after the House passed the measure by a 222-209 vote…
Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The AHA commented Nov. 3 on the Centers for Medicare & Medicaid Services’ calendar year 2026 final rule for the physician fee schedule. The rule, released…